Two critical factors that affect the prognosis of bladder cancer patients are high-grade invasive tumors and the high rate of tumor recurrence. Hyaluronidase is an enzyme that degrades hyaluronic acid (HA), a glycosaminoglycan, into small angiogenic fragments. Two hyaluronidases have been identified as potential """"""""molecular markers"""""""" of high-grade bladder tumors (BT). The long-term objectives of this proposal are to elucidate functions of these hyaluronidases in BT progression and to develop a simple, non-invasive and accurate test for early detection and post-therapy surveillance of bladder cancer. To test the hypothesis that BT-derived hyaluronidases are structurally distinct from other known hyaluronidases and are expressed in a tumor, tissue, or cell specific manner, BT-derived hyaluronidases will be isolated, purified, cDNA cloned and sequenced (Aim 1). These enzymes will be characterized for substrate specificity and sensitivity to inhibitors and their expression will be examined at protein and mRNA levels in normal tissues, tumor tissues, and tumor cells (Aim 2). To test whether elevated BT-derived hyaluronidase levels confer metastatic phenotype to otherwise indolent BT cells, low-grade BT cells will be transfected with cDNAs of these enzymes and following orthotopic implantation in nude mice metastasis will be examined. In addition, the role of angiogenic HA fragments on functions of BT cells and BT-derived endothelial cells which regulate BT progression will be examined (Aim 3). Urinary HA levels are elevated in BT patients and urinary hyaluronidase levels are elevated in patients with high-grade BT. To test whether a HA-hyaluronidase test can detect bladder tumor recurrence and indicate its malignant potential, urinary HA-hyaluronidase levels in 150 BT patients will be measured at scheduled surveillance visits and results will be compared with cystoscopic or urine cytology findings (Aim 4). The proposed study could result in identifying and functionally characterizing a new marker of high-grade BT which could improve diagnosis and treatment of bladder cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA072821-04
Application #
6137588
Study Section
Pathology B Study Section (PTHB)
Program Officer
Aamodt, Roger L
Project Start
1997-01-01
Project End
2001-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
4
Fiscal Year
2000
Total Cost
$107,100
Indirect Cost
Name
University of Miami School of Medicine
Department
Urology
Type
Schools of Medicine
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33146
Hautmann, S H; Lokeshwar, V B; Schroeder, G L et al. (2001) Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer. J Urol 165:2068-74
Lokeshwar, V B; Soloway, M S (2001) Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 165:1067-77
Lokeshwar, V B; Rubinowicz, D; Schroeder, G L et al. (2001) Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 276:11922-32
Hautmann, S H; Schroeder, G L; Civantos, F et al. (2001) [Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers] Urologe A 40:121-6
Lokeshwar, V B; Obek, C; Pham, H T et al. (2000) Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J Urol 163:348-56
Lokeshwar, V B; Block, N L (2000) HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade. Urol Clin North Am 27:53-61
Wei, D C; Politano, V A; Selzer, M G et al. (2000) The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis. J Urol 163:1577-83
Lokeshwar, V B; Young, M J; Goudarzi, G et al. (1999) Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res 59:4464-70
Lokeshwar, V B; Soloway, M S; Block, N L (1998) Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells. Cancer Lett 131:21-7